MovDisordV3, PubMed, Curation, bibRecord, 002591

Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease.

Identifieur interne : 002591 ( PubMed/Curation ); précédent : 002590; suivant : 002592

Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease.

Auteurs : Adeline Gallini ; Agnès Sommet ; Anne-Marie Salandini ; Patrick Veyssière ; Jean-Louis Montastruc ; Jean-Louis Montastruc

Source :

Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2007.

RBID : pubmed:17657810

English descriptors

KwdEn :
- Adverse Drug Reaction Reporting Systems, Aged, Anorexia (chemically induced), Antiparkinson Agents (adverse effects), Antiparkinson Agents (therapeutic use), Cholinesterase Inhibitors (adverse effects), Cholinesterase Inhibitors (therapeutic use), Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Therapy, Combination, Female, Galantamine (adverse effects), Galantamine (therapeutic use), Humans, Lewy Body Disease (drug therapy), Memantine (adverse effects), Memantine (therapeutic use), Mental Status Schedule, Nausea (chemically induced), Nootropic Agents (adverse effects), Nootropic Agents (therapeutic use), Parkinson Disease (drug therapy), Vomiting (chemically induced), Weight Loss (drug effects).
MESH :
- chemical , adverse effects : Antiparkinson Agents, Cholinesterase Inhibitors, Galantamine, Memantine, Nootropic Agents.
- chemically induced : Anorexia, Nausea, Vomiting.
- drug effects : Weight Loss.
- drug therapy : Lewy Body Disease, Parkinson Disease.
- chemical , therapeutic use : Antiparkinson Agents, Cholinesterase Inhibitors, Galantamine, Memantine, Nootropic Agents.
- Adverse Drug Reaction Reporting Systems, Aged, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Therapy, Combination, Female, Humans, Mental Status Schedule.

DOI: 10.1002/mds.21669
PubMed: 17657810

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002591

Links to Exploration step

pubmed:17657810

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease.</title>
<author><name sortKey="Gallini, Adeline" sort="Gallini, Adeline" uniqKey="Gallini A" first="Adeline" last="Gallini">Adeline Gallini</name>
</author>
<author><name sortKey="Sommet, Agnes" sort="Sommet, Agnes" uniqKey="Sommet A" first="Agnès" last="Sommet">Agnès Sommet</name>
</author>
<author><name sortKey="Salandini, Anne Marie" sort="Salandini, Anne Marie" uniqKey="Salandini A" first="Anne-Marie" last="Salandini">Anne-Marie Salandini</name>
</author>
<author><name sortKey="Veyssiere, Patrick" sort="Veyssiere, Patrick" uniqKey="Veyssiere P" first="Patrick" last="Veyssière">Patrick Veyssière</name>
</author>
<author><name sortKey="Montastruc, Jean Louis" sort="Montastruc, Jean Louis" uniqKey="Montastruc J" first="Jean-Louis" last="Montastruc">Jean-Louis Montastruc</name>
</author>
<author><name sortKey="Montastruc, Jean Louis" sort="Montastruc, Jean Louis" uniqKey="Montastruc J" first="Jean-Louis" last="Montastruc">Jean-Louis Montastruc</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="doi">10.1002/mds.21669</idno>
<idno type="RBID">pubmed:17657810</idno>
<idno type="pmid">17657810</idno>
<idno type="wicri:Area/PubMed/Corpus">002591</idno>
<idno type="wicri:Area/PubMed/Curation">002591</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease.</title>
<author><name sortKey="Gallini, Adeline" sort="Gallini, Adeline" uniqKey="Gallini A" first="Adeline" last="Gallini">Adeline Gallini</name>
</author>
<author><name sortKey="Sommet, Agnes" sort="Sommet, Agnes" uniqKey="Sommet A" first="Agnès" last="Sommet">Agnès Sommet</name>
</author>
<author><name sortKey="Salandini, Anne Marie" sort="Salandini, Anne Marie" uniqKey="Salandini A" first="Anne-Marie" last="Salandini">Anne-Marie Salandini</name>
</author>
<author><name sortKey="Veyssiere, Patrick" sort="Veyssiere, Patrick" uniqKey="Veyssiere P" first="Patrick" last="Veyssière">Patrick Veyssière</name>
</author>
<author><name sortKey="Montastruc, Jean Louis" sort="Montastruc, Jean Louis" uniqKey="Montastruc J" first="Jean-Louis" last="Montastruc">Jean-Louis Montastruc</name>
</author>
<author><name sortKey="Montastruc, Jean Louis" sort="Montastruc, Jean Louis" uniqKey="Montastruc J" first="Jean-Louis" last="Montastruc">Jean-Louis Montastruc</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adverse Drug Reaction Reporting Systems</term>
<term>Aged</term>
<term>Anorexia (chemically induced)</term>
<term>Antiparkinson Agents (adverse effects)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Cholinesterase Inhibitors (adverse effects)</term>
<term>Cholinesterase Inhibitors (therapeutic use)</term>
<term>Dose-Response Relationship, Drug</term>
<term>Drug Administration Schedule</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Galantamine (adverse effects)</term>
<term>Galantamine (therapeutic use)</term>
<term>Humans</term>
<term>Lewy Body Disease (drug therapy)</term>
<term>Memantine (adverse effects)</term>
<term>Memantine (therapeutic use)</term>
<term>Mental Status Schedule</term>
<term>Nausea (chemically induced)</term>
<term>Nootropic Agents (adverse effects)</term>
<term>Nootropic Agents (therapeutic use)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Vomiting (chemically induced)</term>
<term>Weight Loss (drug effects)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Cholinesterase Inhibitors</term>
<term>Galantamine</term>
<term>Memantine</term>
<term>Nootropic Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Anorexia</term>
<term>Nausea</term>
<term>Vomiting</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Weight Loss</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Lewy Body Disease</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Cholinesterase Inhibitors</term>
<term>Galantamine</term>
<term>Memantine</term>
<term>Nootropic Agents</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adverse Drug Reaction Reporting Systems</term>
<term>Aged</term>
<term>Dose-Response Relationship, Drug</term>
<term>Drug Administration Schedule</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Humans</term>
<term>Mental Status Schedule</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">17657810</PMID>
<DateCreated><Year>2007</Year>
<Month>11</Month>
<Day>05</Day>
</DateCreated>
<DateCompleted><Year>2008</Year>
<Month>03</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print"><Volume>22</Volume>
<Issue>13</Issue>
<PubDate><Year>2007</Year>
<Month>Oct</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease.</ArticleTitle>
<Pagination><MedlinePgn>1980-1</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gallini</LastName>
<ForeName>Adeline</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Sommet</LastName>
<ForeName>Agnès</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Salandini</LastName>
<ForeName>Anne-Marie</ForeName>
<Initials>AM</Initials>
</Author>
<Author ValidYN="Y"><LastName>Veyssière</LastName>
<ForeName>Patrick</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y"><LastName>Montastruc</LastName>
<ForeName>Jean-Louis</ForeName>
<Initials>JL</Initials>
</Author>
<Author ValidYN="Y"><LastName>Montastruc</LastName>
<ForeName>Jean-Louis</ForeName>
<Initials>JL</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002800">Cholinesterase Inhibitors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018697">Nootropic Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0D3Q044KCA</RegistryNumber>
<NameOfSubstance UI="D005702">Galantamine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>W8O17SJF3T</RegistryNumber>
<NameOfSubstance UI="D008559">Memantine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D016907">Adverse Drug Reaction Reporting Systems</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000855">Anorexia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000139">chemically induced</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000978">Antiparkinson Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D002800">Cholinesterase Inhibitors</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004305">Dose-Response Relationship, Drug</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004334">Drug Administration Schedule</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004359">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005702">Galantamine</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D020961">Lewy Body Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008559">Memantine</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008609">Mental Status Schedule</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009325">Nausea</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000139">chemically induced</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D018697">Nootropic Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D014839">Vomiting</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000139">chemically induced</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D015431">Weight Loss</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year>
<Month>7</Month>
<Day>28</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2008</Year>
<Month>3</Month>
<Day>22</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2007</Year>
<Month>7</Month>
<Day>28</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="doi">10.1002/mds.21669</ArticleId>
<ArticleId IdType="pubmed">17657810</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002591 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002591 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:17657810
   |texte=   Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:17657810" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease.

Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease.

Source :

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki